-
Markeder
athexgroup.grAthens Exchange GroupLes merTogether for a unified, stronger European capital market.
-
Aksjer
Sustainable finance2025 Euronext ESG Trends ReportLes merA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indekser
Access the white paperInvesting in the future of Europe with innovative indicesLes merThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETF-er
The European market place for ETFsEuronext ETF EuropeLes merInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fond
-
Obligasjoner
European Defence BondsGroupe BPCE lists the first bondLes merFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Strukturerte produkter
-
Derivater
Where European Government Bonds Meet the FutureFixed Income derivativesLes merTrade mini bond futures on main European government bonds
-
Råvarer
- Oversikt
- Agricultural quotes
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Container Freight Futures
- Levering og oppgjør
- Spesifikasjoner og ordninger
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesLes merEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Ressurser
Designed to help students navigate the complexities of financial marketsEuronext Trading gameLes merJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Company press releases
| Tid | Selskap | Tittel | Sektor | Kategori |
|---|---|---|---|---|
| 04 Mar 2024 08:15 CET |
VISTIN PHARMA | Vistin Pharma ASA (VISTN) acquires minority share in CF Pharma (Hungary) | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Feb 2024 10:30 CET |
VISTIN PHARMA | Vistin Pharma ASA: Key information relating to the proposed cash dividend | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Feb 2024 07:45 CET |
VISTIN PHARMA | Vistin Pharma ASA: Fourth quarter and preliminary 2023 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 09 Feb 2024 10:00 CET |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q4 2023 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Jan 2024 08:00 CET |
VISTIN PHARMA | Ex dividend NOK 0.75 today | 20103015 Pharmaceuticals | Ex Date |
| 11 Jan 2024 11:40 CET |
VISTIN PHARMA | Key information relating to the cash dividend to be paid by Vistin Pharma ASA | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Jan 2024 11:35 CET |
VISTIN PHARMA | Vistin Pharma ASA: Dividend of NOK 0.75 per share | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 13 Dec 2023 10:21 CET |
VISTIN PHARMA | Financial calendar | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Oct 2023 07:45 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Third quarter 2023 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 25 Oct 2023 07:45 CEST |
VISTIN PHARMA | Vistin Pharma ASA: New CEO appointed | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 18 Oct 2023 13:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q3 2023 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 18 Sep 2023 18:40 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Mandatory notification of trade | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 26 Aug 2023 09:40 CEST |
VISTIN PHARMA | Mandatory notification of trade in Vistin Pharma ASA | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 23 Aug 2023 07:35 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Second quarter and first half 2023 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 16 Aug 2023 12:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q2 2023 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Jul 2023 08:30 CEST |
VISTIN PHARMA | Management in Vistin Pharma ASA purchases shares | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 04 Jul 2023 08:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Results of offer to buy back shares | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Jun 2023 07:30 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Offer to buy back shares | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Jun 2023 13:57 CEST |
VISTIN PHARMA | Financial calendar | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Jun 2023 13:57 CEST |
VISTIN PHARMA | Finansiell kalender | 20103015 Pharmaceuticals | Annen informasjonspliktig regulatorisk informasjon |
| 14 Jun 2023 15:15 CEST |
VISTIN PHARMA | Vistin Pharma ASA (OSE: VISTIN): Presentation from today's Capital Markets Day | 20103015 Pharmaceuticals | Non-regulatory press releases |